procurement

‘Strategic Sourcing’ has played a key role in the success of procurement teams. A dent in this key game plan is “maverick spending.”

Pharmaceutical companies, healthcare providers, research organizations, universities, and government agencies are continuously under pressure to cut costs due to a generalized economic downturn. This pressure has moved the procurement process to the forefront, with managers looking to achieve better business performance through more effective management of categories, suppliers, and teams.1

Problem: A variety of factors can result in obsolete laboratory equipment and R&D devices. Project
completion, equipment upgrade, lab closure, and downsizing all create surplus pharmaceutical assets
no longer required in the same capacity—or at all. Given budget restrictions and the importance placed
on environmentally-sound business practices, organizations can’t afford to allow surplus assets to lie
idle or dispose of them without thought to the process. Surplus requires an innovative and sustainable
process that supports strategic business goals.














